freedom has been researched along with Bone Loss, Perimenopausal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cosman, F; Cummings, SR; Huang, S; McDermott, M | 1 |
| Briganti, EM; Zhu, J | 1 |
1 trial(s) available for freedom and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Multiple Vertebral Fractures After Denosumab Discontinuation: FREEDOM and FREEDOM Extension Trials Additional Post Hoc Analyses.
Topics: Bone Density; Bone Density Conservation Agents; Denosumab; Female; Fracture Fixation; Freedom; Humans; Osteoporosis; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Spinal Fractures | 2022 |
1 other study(ies) available for freedom and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
Letter to the Editor From Zhu and Briganti: "Denosumab Safety and Efficacy Among Participants in the FREEDOM Extension Study With Mild to Moderate Chronic Kidney Disease".
Topics: Bone Density Conservation Agents; Denosumab; Female; Freedom; Humans; Osteoporosis, Postmenopausal; Renal Insufficiency, Chronic | 2021 |